Effect of bimatoprost sustained-release intracameral implant on intraocular pressure and medication burden in patients with prior glaucoma surgery

Single Administration of Intracameral Bimatoprost Implant 10 µg in Patients with Open-Angle Glaucoma or Ocular Hypertension

(2022) Felipe A. Medeiros et al.   Ophthalmology and Therapy

Comparing Five Criteria for Evaluating Glaucomatous Visual Fields

(2021) Herman Stubeda et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

The Association between Medication Adherence and Visual Field Progression in the Collaborative Initial Glaucoma Treatment Study

(2020) Paula Anne Newman-Casey et al.   OPHTHALMOLOGY

Phase 3, Randomized, 20-Month Study of Bimatoprost Implant in Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 1)

(2020) Felipe A. Medeiros et al.   OPHTHALMOLOGY

24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients

(2019) E. Randy Craven et al.   DRUGS

Intracameral Sustained-Release Bimatoprost Implant Delivers Bimatoprost to Target Tissues with Reduced Drug Exposure to Off-Target Tissues

(2018) Jennifer R. Seal et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

The Most Common Barriers to Glaucoma Medication Adherence

(2015) Paula Anne Newman-Casey et al.   OPHTHALMOLOGY

The Pathophysiology and Treatment of Glaucoma

(2014) Robert N. Weinreb et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effects of Common Topical Antiglaucoma Medications on the Ocular Surface, Eyelids and Periorbital Tissue

(2011) J. Javier Servat et al.   DRUGS & AGING

Twelve-Month, Randomized, Controlled Trial of Bimatoprost 0.01%, 0.0125%, and 0.03% in Patients with Glaucoma or Ocular Hypertension

(2010) L. Jay Katz et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Side Effects Associated with Prostaglandin Analog Therapy

(2008) Albert Alm et al.   SURVEY OF OPHTHALMOLOGY